Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Bimekizumab Efficacy in Psoriasis by Subgroups: Post Hoc Analysis of Phase 3/3b Clinical Trials
2025
0 citations
Journal Article
gold Open Access
Field-Weighted Citation Impact:
0.00
Sarah Kavanagh
Bengt Hoepken
·
UCB Pharma (Germany)
Paolo Gisondi
·
University of Verona
Bimekizumab Efficacy in Psoriasis by Subgroups: Post Hoc Analysis of Phase 3/3b Clinical Trials | Researchclopedia